Literature DB >> 12243509

Tumor size, axillary lymph node status and steroid receptor expression in breast cancer: prognostic relevance 5 years after surgery.

Gerhard Gebauer1, Tanja Fehm, Norbert Lang, Wolfram Jäger.   

Abstract

Tumor size, axillary lymph node status and expression of steroid receptors are well-established prognostic factors in breast cancer. However, it is not clear if these prognostic factors are time-dependent variables and lose their significance after several years of disease-free survival. To analyse how long these factors keep their prognostic relevance survival of 1162 breast cancer patients was analysed retrospectively. The post-operative follow-up period was split into consecutive 2-year intervals and each interval was analysed for rate of recurrence and rate of tumor depending deaths. Furthermore, a multivariate analysis was performed for the total follow-up time and for the follow-up period starting 5 years after surgery. Multivariate analysis revealed tumor size, axillary lymph node status and estrogen receptor status as independent prognostic parameters. Analysing separately the rate of recurrences and tumor-related deaths during consecutive 2-year intervals, only the tumor size was a constant prognostic parameter, whereas prognostic relevance of lymph node status decreased. Estrogen receptor status associated with favourable prognosis during the first years after surgery changed to an unfavourable prognostic factor 4 years after surgery. To summarize, prognostic factors obtained at the time of surgery can lose their significance with increasing disease-free survival.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12243509     DOI: 10.1023/a:1019601928290

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  7 in total

Review 1.  Prognostic value of survivin expression in breast cancer patients: a meta-analysis.

Authors:  Jian Song; Hong Su; Yang-Yang Zhou; Liang-Liang Guo
Journal:  Tumour Biol       Date:  2013-05-21

Review 2.  Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.

Authors:  Fei Pan; Hui Mao; Ling Deng; Guangchao Li; Peiliang Geng
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Adjuvant chemotherapy in 780 patients with early breast cancer: 10-year data from Saudi Arabia.

Authors:  Ezzeldin M Ibrahim; Adnan A Ezzat; Mohammed M Rahal; Madras M Raja; Dahish S Ajarim
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

4.  Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.

Authors:  Anna-Karin Falck; Pär-Ola Bendahl; Christian Ingvar; Jorma Isola; Per-Ebbe Jönsson; Pia Lindblom; Kristina Lövgren; Karin Rennstam; Mårten Fernö; Lisa Rydén
Journal:  BMC Cancer       Date:  2012-09-11       Impact factor: 4.430

5.  Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran.

Authors:  Abbas Rezaianzadeh; Janet Peacock; Daniel Reidpath; Abdolrasoul Talei; Seyed Vahid Hosseini; Davood Mehrabani
Journal:  BMC Cancer       Date:  2009-06-05       Impact factor: 4.430

6.  Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients.

Authors:  A R Hinnis; J C A Luckett; R A Walker
Journal:  Br J Cancer       Date:  2007-02-06       Impact factor: 7.640

7.  Role of postmastectomy radiation therapy in breast cancer patients with T1-2 and 1-3 positive lymph nodes.

Authors:  Yasemin Benderli Cihan; Talha Sarigoz
Journal:  Onco Targets Ther       Date:  2016-09-09       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.